Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Greenphire and Oracle to Work Together

Published: Tuesday, June 25, 2013
Last Updated: Tuesday, June 25, 2013
Bookmark and Share
New partnership to automate clinical trial planning, budgeting and payments.

Greenphire has announced a relationship with Oracle Health Sciences. Oracle and Greenphire are integrating their respective product suites to enable their clients to streamline and automate processes from trial planning and budgeting, all the way through data capture to executing payments to clinical sites and patients, while providing real-time, strategically valuable reporting and analytics.

The first initiative will be the integration of Greenphire’s global payment platform, eClinicalGPS, with Oracle’s electronic data capture (EDC) solutions, Oracle Health Sciences InForm and Oracle Remote Data Capture (RDC).

This integration will help ensure that clients have quick product implementations without relying on internal development and staffing.

Data sharing between EDC and payment technologies will enable a virtually seamless transition between the collection and capture of clinical data and the accurate execution of payments.

Greenphire and Oracle are currently working with three joint clients including two top 10 global biopharmaceutical clients and a fast growing biotechnology client.

“Clinical trial sponsors and their CRO partners are focused on improving productivity and efficiency across their clinical programs - including study set up, recruitment, data collection and analysis, as well as the administration of and payments to research sites and participants. Integrations between the Oracle and Greenphire product suites can help biopharmaceutical companies and CROs achieve new levels of efficiency and deliver powerful analytics that support continuous improvement. This will enable companies to re-direct freed up resources to discovery and development initiatives,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences.

“Greenphire is committed to continually finding ways to increase efficiencies in clinical research processes and to drive value and cost savings for our clients,” said Greenphire Founder & CEO Sam Whitaker.

Whitaker continued, “Our relationship with Oracle is a tremendous opportunity to find innovative ways to streamline existing processes and to ultimately simplify financial planning and management of clinical trials, by working with a company that offers world-class e-clinical solutions.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Greenphire Awards $35,000 to Three Health and Wellness Nonprofits
NO MORE received a donation of $20,000 to further its mission to end domestic violence and sexual assault.
Wednesday, June 25, 2014
Greenphire Appoints Senior Director of Business Development in Europe
Alex Livingstone brings more than 12 years of eClinical software, pharmaceutical and biotechnology industry experience to the company.
Thursday, October 10, 2013
Greenphire Named One of the Fastest-Growing U.S Companies
The company has been ranked in the 2013 Inc. Magazine 500 list of the fastest-growing private companies in the U.S.
Wednesday, August 21, 2013
Greenphire and Ernst & Young Announce Strategic Partnership
Partnership will combine eClinicalGPS technology with the global intellectual property and expertise of Ernst & Young.
Wednesday, July 10, 2013
Greenphire and IMS Health Announce Strategic Integration
Launch of strategic integration of eClinicalGPS and GrantPlan.
Friday, June 21, 2013
Greenphire's John Samar Named CFO of the Year Finalist
The Philadelphia Business Journal awards honour professionals who have displayed outstanding performance in their roles as corporate financial leaders.
Wednesday, May 29, 2013
Greenphire CEO Selected as Finalist in Ernst & Young Awards
CEO Sam Whitaker has been selected as a finalist for the Ernst & Young Entrepreneur of the Year Awards 2013 in the Greater Philadelphia region.
Friday, May 17, 2013
Greenphire Announces New London Office
Plans to facilitate expansion in Europe.
Tuesday, May 07, 2013
Greenphire Appoints UK-based Global Product Manager
Appointment of Rory O’Hare to facilitate European growth.
Thursday, February 21, 2013
Greenphire Supports Proposed EU Legislation to Reduce Clinical Trial Administration
The proposed legislation expected to be enacted by 2016.
Friday, July 27, 2012
Greenphire Appoints Chief Commercial Officer
Appointment of John M Blakeley to the role of Chief Commercial Officer.
Thursday, July 12, 2012
Greenphire and Merge Healthcare Form Exclusive Partnership
Partnership to integrate clinical payment and EDC platforms.
Wednesday, May 09, 2012
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Multi-Gene Test Enables Some Breast Cancer Patients to Safely Avoid Chemotherapy
A major study is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack?
Heart attack patients live as long – or even longer – on one-quarter the suggested dose.
Antidepressants Plus Blood-Thinners Slow Down Brain Cancer
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Electronic Reminders Keep TB Patients on Track With Medication In China
Giving electronic reminders to tuberculosis (TB) patients in China can reduce the amount of medication doses they miss by half, according to new research.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos